
TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00035.x
DO  - doi:10.1111/j.1538-7836.2007.tb00035.x
SP  - P-W-401
EP  - P-W-701
PY  - 2007
ER  - 

TY  - JOUR
TI  - XVIth Annual Meeting of Pan American Society for Pigment Cell Research Vancouver Pigmentation and Melanoma Research Conference “The latest developments in the research and treatment of pigmentation conditions and melanoma”
JO  - Pigment Cell & Melanoma Research
VL  - 23
IS  - 5
SN  - 1755-1471
UR  - https://doi.org/10.1111/j.1755-148X.2010.00747.x
DO  - doi:10.1111/j.1755-148X.2010.00747.x
SP  - 695
EP  - 721
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Journal of Diabetes
VL  - 3
IS  - s1
SN  - 1753-0393
UR  - https://doi.org/10.1111/j.1753-0407.2011.00122.x
DO  - doi:10.1111/j.1753-0407.2011.00122.x
SP  - 42
EP  - 281
PY  - 2011
ER  - 

TY  - JOUR
TI  - Paper Session
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 65
IS  - S2
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.15055
DO  - doi:10.1111/jgs.15055
SP  - S295
EP  - S369
PY  - 2017
ER  - 

TY  - JOUR
AU  - Leiper , Alison D.
TI  - Non-endocrine late complications of bone marrow transplantation in childhood: part II
JO  - British Journal of Haematology
VL  - 118
IS  - 1
SN  - 0007-1048
UR  - https://doi.org/10.1046/j.1365-2141.2002.03471.x
DO  - doi:10.1046/j.1365-2141.2002.03471.x
SP  - 23
EP  - 43
KW  - bone marrow transplantation
KW  - late complications
KW  - children
KW  - total body irradiation
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts of papers to be presented at the sixteenth annual meeting of the American Society of Primatologists August 18–22, 1993 Sturbridge, Massachusetts
JO  - American Journal of Primatology
JA  - Am. J. Primatol.
VL  - 30
IS  - 4
SN  - 0275-2565
UR  - https://doi.org/10.1002/ajp.1350300403
DO  - doi:10.1002/ajp.1350300403
SP  - 293
EP  - 362
PY  - 1993
ER  - 

TY  - JOUR
TI  - Abstracts of the Eleventh Symposium on Neurogastroenterology and Motility
JO  - Neurogastroenterology & Motility
VL  - 14
IS  - 5
SN  - 1350-1925
UR  - https://doi.org/10.1046/j.1365-2982.2002.00360.x
DO  - doi:10.1046/j.1365-2982.2002.00360.x
SP  - 561
EP  - 606
PY  - 2002
ER  - 

TY  - JOUR
TI  - American Society of Cytopathology 56th Annual Scientific Meeting Platform and Poster Presentations
JO  - Cancer Cytopathology
JA  - Cancer
VL  - 114
IS  - S5
SN  - 0008-543X
UR  - https://doi.org/10.1002/cncr.23847
DO  - doi:10.1002/cncr.23847
SP  - 343
EP  - 461
PY  - 2008
ER  - 

TY  - JOUR
TI  - Pharmacoepidemiology and drug safety
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 2
IS  - 4‐5
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.2630020414
DO  - doi:10.1002/pds.2630020414
SP  - 523
EP  - 554
PY  - 1993
ER  - 

TY  - JOUR
TI  - Contributed Poster Presentations  Session I
JO  - Value in Health
VL  - 4
IS  - 6
SN  - 1098-3015
UR  - https://doi.org/10.1046/j.1524-4733.2001.46003.x
DO  - doi:10.1046/j.1524-4733.2001.46003.x
SP  - 421
EP  - 471
PY  - 2001
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - HIV Medicine
VL  - 6
IS  - s1
SN  - 1464-2662
UR  - https://doi.org/10.1111/j.1468-1293.2005.00297_2.x
DO  - doi:10.1111/j.1468-1293.2005.00297_2.x
SP  - 14
EP  - 55
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Sessions Wednesday/Thursday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 150
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.14777
DO  - doi:10.1111/jnc.14777
SP  - 162
EP  - 251
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - HIV Medicine
VL  - 6
IS  - s1
SN  - 1464-2662
UR  - https://doi.org/10.1111/j.1468-1293.2005.00297_1.x
DO  - doi:10.1111/j.1468-1293.2005.00297_1.x
SP  - 1
EP  - 13
PY  - 2005
ER  - 

TY  - JOUR
TI  - Free Oral
JO  - HPB
JA  - HPB
VL  - 16
IS  - s2
SN  - 1365-182X
UR  - https://doi.org/10.1111/hpb.12229
DO  - doi:10.1111/hpb.12229
SP  - 128
EP  - 241
PY  - 2014
ER  - 

TY  - JOUR
TI  - Invited Speakers and Oral Abstracts of the 2009 Joint Meeting of the International Pancreas and Islet Transplant Association (IPITA) and the International Xenotransplantation Association (IXA)
JO  - Xenotransplantation
VL  - 16
IS  - 5
SN  - 0908-665X
UR  - https://doi.org/10.1111/j.1399-3089.2009.00539_2.x
DO  - doi:10.1111/j.1399-3089.2009.00539_2.x
SP  - 286
EP  - 329
PY  - 2009
ER  - 

TY  - JOUR
AU  - Tobin, Nicole H.
AU  - Aldrovandi, Grace M.
TI  - Immunology of pediatric HIV infection
JO  - Immunological Reviews
JA  - Immunol Rev
VL  - 254
IS  - 1
SN  - 0105-2896
UR  - https://doi.org/10.1111/imr.12074
DO  - doi:10.1111/imr.12074
SP  - 143
EP  - 169
KW  - HIV
KW  - children
KW  - neonatal
KW  - gut microbiota
KW  - breast milk
KW  - Th17
KW  - regulatory T-cells
PY  - 2013
AB  - Summary Most infants born to human immunodeficiency virus (HIV)-infected women escape HIV infection. Infants evade infection despite an immature immune system and, in the case of breastfeeding, prolonged repetitive exposure. If infants become infected, the course of their infection and response to treatment differs dramatically depending upon the timing (in utero, intrapartum, or during breastfeeding) and potentially the route of their infection. Perinatally acquired HIV infection occurs during a critical window of immune development. HIV's perturbation of this dynamic process may account for the striking age-dependent differences in HIV disease progression. HIV infection also profoundly disrupts the maternal immune system upon which infants rely for protection and immune instruction. Therefore, it is not surprising that infants who escape HIV infection still suffer adverse effects. In this review, we highlight the unique aspects of pediatric HIV transmission and pathogenesis with a focus on mechanisms by which HIV infection during immune ontogeny may allow discovery of key elements for protection and control from HIV.
ER  - 

TY  - JOUR
TI  - ISLH 2019 Abstracts
JO  - International Journal of Laboratory Hematology
JA  - Int J Lab Hem
VL  - 41
IS  - S2
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.13105
DO  - doi:10.1111/ijlh.13105
SP  - 1
EP  - 205
PY  - 2019
ER  - 

AU  - Shanahan, Fergus
C7  - pp. 355-371
TI  - Ulcerative Colitis
SN  - 9781405191821
UR  - https://doi.org/10.1002/9781118321386.ch49
DO  - doi:10.1002/9781118321386.ch49
SP  - 355-371
KW  - Inflammatory bowel disease
KW  - Ulcerative colitis
KW  - Cytokine
KW  - Microbiota
KW  - Mucosa
KW  - Immunity
PY  - 2019
AB  - Summary Ulcerative colitis is a chronic relapsing inflammatory disease sharing many features with Crohn's disease but differing in being confined to the colonic mucosa, without proximal involvement or penetration to the deeper layers of the bowel, in uncomplicated cases. Ulcerative colitis has changed face over time; once considered rare, it is now a major gastroenterologic problem in the developed world with changing demographics. The first controlled clinical therapeutic trial of corticosteroids in ulcerative colitis half century ago highlighted gastroenterology as an early exponent of evidence-based medicine. More recently, the prognosis of patients with severe disease has improved with attention to detail, critical care and the advent of immunomodulatory agents. However, despite remarkable advances, ulcerative colitis remains a significant burden on healthcare resources and a cause of much individual suffering.
ER  - 

AU  - Kullmann, Dimitri
AU  - Houlden, Henry
AU  - Lunn, Michael
C7  - pp. 69-95
TI  - Mechanisms of Neurological Disease
SN  - 9781118486177
UR  - https://doi.org/10.1002/9781118486160.ch3
DO  - doi:10.1002/9781118486160.ch3
SP  - 69-95
KW  - autoimmunity
KW  - channelopathies
KW  - genetic disease
KW  - immune system
KW  - ion channels
KW  - mutation
KW  - neurological disease
PY  - 2019
AB  - Summary Many neurological diseases share pathological processes that require an understanding of genetics or immunity. This chapter considers these from the perspective of the molecular lesion rather than the clinical manifestation. It examines abnormalities of ion channels, which can be affected by either inherited mutations or autoantibodies. The chapter then deals with genetic disorders and neuro-immunology. Genetic diseases can be divided into five main categories: Abnormalities in the structure or complement of chromosomes (chromosomal disorders), Mutations or other defects affecting a gene; Nucleotide repeat expansions; Mendelian disorders that are likely to be caused by digenic or epistatic inheritance; and Conditions in which genetic and environmental factors interact.The immune system distinguishes the self from non-self organisms and acts to delete, disable or inactivate foreign invaders. Neurological channelopathies potentially identify signalling pathways and circuits involved in diseases that account for a large fraction of neurological practice.
ER  - 

TY  - JOUR
TI  - Print-only Abstract
JO  - HIV Medicine
VL  - 6
IS  - s1
SN  - 9781118486177
UR  - https://doi.org/10.1111/j.1468-1293.2005.00297_3.x
DO  - doi:10.1111/j.1468-1293.2005.00297_3.x
SP  - 56
EP  - 59
PY  - 2005
ER  - 
